TYRA Tyra Biosciences, Inc.
Healthcare$32.47-1.67%ClosedMarket Cap: $1.93B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
5.17
P/S
0.00
EV/EBITDA
-13.29
DCF Value
$1.18
FCF Yield
-5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-42.7%
ROA
-31.8%
ROIC
-36.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-42.0M | $-39.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-36.5M | $-33.8M | $— | — |
| FY null | $0.00 | NaN% | $-132.8M | $-119.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-32.9M | $-29.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-31.5M | $-28.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-31.9M | $-28.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-29.7M | $-25.6M | $— | — |
| FY null | $0.00 | NaN% | $-104.2M | $-86.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.6M | $-24.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-23.5M | $-18.7M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-22.3M | $-18.2M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-25.6M | $-22.8M | $-0.53 | — |